During the past decade, Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda" #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "Janssen Research & Development, LLC" with 5 trials sponsored, "Merck Sharp & Dohme LLC" with 2 trials sponsored, "NovoCure Ltd." with 1 trials sponsored and "PharmaMar" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda" #1 collaborator was "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator and "Institut Jules Bordet/Clinical Trials Support Unit (IJB/CTSU)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda" are "Breast Cancer" (2 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials), "Advanced or Metastatic Esophageal Squamous Cell Carcinoma" (1 trials), "Castration-Resistant Prostatic Cancer" (1 trials) and "Lung Neoplasms" (1 trials). Many other conditions were trialed in "Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda" in a lesser frequency.

Most popular intervention types in "Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda" are "Drug" (14 trials), "Biological" (2 trials), "Device" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (6 trials), "Placebo" (4 trials), "Amivantamab" (2 trials), "Tiragolumab" (2 trials) and "Abiraterone Acetate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda" are 13 trials for "All" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda". undefined are not yet recruiting, 7 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda has several departments that took part in Clinical trials: "Oncosite - Centro de Pesquisa Clinica Em Oncologia" - 2 trials